Rizos H - Search Results

1

Acquired BRAF inhibitor resistance: A multicenter meta-analysis of the spectrum and frequencies, clinical behaviour, and phenotypic associations of resistance mechanisms.

Johnson DB, Menzies AM, Zimmer L, Eroglu Z, Ye F, Zhao S, Rizos H, Sucker A, Scolyer RA, Gutzmer R, Gogas H, Kefford RF, Thompson JF, Becker JC, Berking C, Egberts F, Loquai C, Goldinger SM, Pupo GM, Hugo W, Kong X, Garraway LA, Sosman JA, Ribas A, Lo RS, Long GV, Schadendorf D. Johnson DB, et al. Among authors: rizos h. Eur J Cancer. 2015 Dec;51(18):2792-9. doi: 10.1016/j.ejca.2015.08.022. Epub 2015 Nov 19. Eur J Cancer. 2015. PMID: 26608120 Free PMC article.

2

SERS characterization of colorectal cancer cell surface markers upon anti-EGFR treatment.

Lyu N, Pedersen B, Shklovskaya E, Rizos H, Molloy MP, Wang Y. Lyu N, et al. Among authors: rizos h. Exploration (Beijing). 2022 May 9;2(3):20210176. doi: 10.1002/EXP.20210176. eCollection 2022 Jun. Exploration (Beijing). 2022. PMID: 37323700 Free PMC article.

3

Analysis of the p16 gene, CDKN2, in 17 Australian melanoma kindreds.

Holland EA, Beaton SC, Becker TM, Grulet OM, Peters BA, Rizos H, Kefford RF, Mann GJ. Holland EA, et al. Among authors: rizos h. Oncogene. 1995 Dec 7;11(11):2289-94. Oncogene. 1995. PMID: 8570179

4

Differential expression of p16INK4a and p16beta transcripts in B-lymphoblastoid cells from members of hereditary melanoma families without CDKN2A exon mutations.

Rizos H, Becker TM, Holland EA, Kefford RF, Mann GJ. Rizos H, et al. Oncogene. 1997 Jul 31;15(5):515-23. doi: 10.1038/sj.onc.1201217. Oncogene. 1997. PMID: 9247305

5

Multiple abnormalities of the p16INK4a-pRb regulatory pathway in cultured melanoma cells.

Rizos H, Darmanian AP, Indsto JO, Shannon JA, Kefford RF, Mann GJ. Rizos H, et al. Melanoma Res. 1999 Feb;9(1):10-9. doi: 10.1097/00008390-199902000-00003. Melanoma Res. 1999. PMID: 10338330

6

Two arginine rich domains in the p14ARF tumour suppressor mediate nucleolar localization.

Rizos H, Darmanian AP, Mann GJ, Kefford RF. Rizos H, et al. Oncogene. 2000 Jun 15;19(26):2978-85. doi: 10.1038/sj.onc.1203629. Oncogene. 2000. PMID: 10871849

7

Mutations in the INK4a/ARF melanoma susceptibility locus functionally impair p14ARF.

Rizos H, Darmanian AP, Holland EA, Mann GJ, Kefford RF. Rizos H, et al. J Biol Chem. 2001 Nov 2;276(44):41424-34. doi: 10.1074/jbc.M105299200. Epub 2001 Aug 22. J Biol Chem. 2001. PMID: 11518711 Free article.

8

A melanoma-associated germline mutation in exon 1beta inactivates p14ARF.

Rizos H, Puig S, Badenas C, Malvehy J, Darmanian AP, Jiménez L, Milà M, Kefford RF. Rizos H, et al. Oncogene. 2001 Sep 6;20(39):5543-7. doi: 10.1038/sj.onc.1204728. Oncogene. 2001. PMID: 11571653

9

Functional impairment of melanoma-associated p16(INK4a) mutants in melanoma cells despite retention of cyclin-dependent kinase 4 binding.

Becker TM, Rizos H, Kefford RF, Mann GJ. Becker TM, et al. Among authors: rizos h. Clin Cancer Res. 2001 Oct;7(10):3282-8. Clin Cancer Res. 2001. PMID: 11595726

10

Association of p14ARF with the p120E4F transcriptional repressor enhances cell cycle inhibition.

Rizos H, Diefenbach E, Badhwar P, Woodruff S, Becker TM, Rooney RJ, Kefford RF. Rizos H, et al. J Biol Chem. 2003 Feb 14;278(7):4981-9. doi: 10.1074/jbc.M210978200. Epub 2002 Nov 21. J Biol Chem. 2003. PMID: 12446718 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

142 results

Search Page

Filters